Compare StocksAMD vs HCA

Advanced Micro Devices, Inc. (AMD) vs HCA Healthcare, Inc. (HCA): Which Is the Better Buy in 2026?

As of 2026-06-19, AMD is overvalued at $537, with a DCF intrinsic value of $219 and a margin of safety of -145%. HCA is undervalued at $375, with an intrinsic value of $523 and a margin of safety of 28%. Of the two, HCA has the wider margin of safety.

AMD
Advanced Micro Devices, Inc.
$537.37
VS
HCA
HCA Healthcare, Inc.
$375.17

Rewards

AMD
  • Free cash flow has grown at a 29.3% CAGR over the past 4 years, demonstrating strong earnings power growth.
  • Each dollar of retained earnings has created $2.01 of earning power — management is an exceptional capital allocator.
  • Management has timed buybacks well — 3 out of 4 years showed value-accretive repurchases.
HCA
  • HCA Healthcare, Inc. has maintained ROIC above 15% for 4 consecutive years, indicating a durable competitive advantage.
  • HCA Healthcare, Inc. scores 95/100 on the Economic Moat Score (Wide Moat), with roic consistency as the strongest competitive dimension.
  • Free cash flow has grown at a 23.1% CAGR over the past 4 years, demonstrating strong earnings power growth.

Risks

AMD
  • Despite buyback spending, shares outstanding increased in 3 out of 4 years — stock-based compensation is offsetting repurchases.
  • FCF yield of 0.8% is below 3%, meaning the market is pricing in substantial future growth to justify the current price.
  • Trailing P/E of 179.7x is 30% above the historical average of 138.5x — the stock trades at a premium to its own history.
HCA

    Key Valuation Metrics

    Learn more →
    AMD
    HCA
    Valuation
    $7.17B
    Free Cash Flow
    $7.69B
    0.82%
    FCF Yield
    9.24%
    179.72
    Trailing P/E
    12.93
    41.01
    Forward P/E
    11.33
    Quality & Moat
    6.23%
    ROIC
    18.14%
    8.06%
    ROE
    N/A
    53.06%
    Gross Margin
    41.61%
    1.22
    PEG Ratio
    1.20
    Balance Sheet Safety
    Net cash
    Net Debt / Equity
    N/A
    N/A
    Interest Coverage
    N/A
    -1.14
    Net Debt / EBITDA
    3.13
    0.00%
    Dividend Yield
    0.76%
    AMD: 2Ties: 2HCA: 6
    AMDHCA

    Historical Fundamentals

    Learn more →
    AMD

    Price ÷ Earnings Per Share — how many years of current earnings you're paying for at today's price. Lower P/E may indicate undervaluation. The dashed forward point is the forward P/E — today's price ÷ analyst consensus EPS.

    HCA

    Price ÷ Earnings Per Share — how many years of current earnings you're paying for at today's price. Lower P/E may indicate undervaluation. The dashed forward point is the forward P/E — today's price ÷ analyst consensus EPS.

    Price ÷ Earnings Per Share — how many years of current earnings you're paying for at today's price. Lower P/E may indicate undervaluation. The dashed forward point is the forward P/E — today's price ÷ analyst consensus EPS.

    $1 Retained Earnings Test

    Learn more →
    AMD
    $35.82
    created per $1 retained over 3 years
    Exceptional Value Creator
    Σ Retained
    $6.83B
    Δ Market Cap
    +$244.67B
    Buffett's "$1 Test": For every $1 of earnings retained, has management created at least $1 of market value?
    > $1 created per $1 retained = Value Creator · < $1 created = Value Destroyer
    HCA
    $2.43
    created per $1 retained over 3 years
    Exceptional Value Creator
    Σ Retained
    $15.76B
    Δ Market Cap
    +$38.30B
    Buffett's "$1 Test": For every $1 of earnings retained, has management created at least $1 of market value?
    > $1 created per $1 retained = Value Creator · < $1 created = Value Destroyer

    Buffett's "$1 Test": For every $1 of earnings retained, has management created at least $1 of market value?
    > $1 created per $1 retained = Value Creator · < $1 created = Value Destroyer

    Discounted Cash Flow (DCF) Analysis

    Learn more →
    AMD
    78.1% Overvalued
    Price is 78.1% above estimated fair value
    Current Price: $537.37
    Fair Value: $301.68
    Strongly undervalued
    Undervalued
    Fairly valued
    Overvalued
    Strongly overvalued
    HCA
    28.2% Margin of Safety
    Price is 28.2% below estimated fair value
    Current Price: $375.17
    Fair Value: $522.55
    Strongly undervalued
    Undervalued
    Fairly valued
    Overvalued
    Strongly overvalued

    Reverse DCF — Market-Implied Growth

    Learn more →
    AMD

    What growth rate is the market pricing in at $537?

    +34.4%
    Market-Implied Owner Earnings Growth
    Standard FCF implies +32.6%

    The market implies +34.4% Owner Earnings growth, above historical trends.

    Standard FCF implies a demanding +32.6%, reflecting heavy growth investment.

    HCA

    What growth rate is the market pricing in at $375?

    +7.3%
    Market-Implied Owner Earnings Growth
    Standard FCF implies +5.6%

    The market implies +7.3% Owner Earnings growth, roughly in line with history — reasonably priced.

    Standard FCF implies +5.6%, reflecting ongoing growth investment.

    Economic Moat Score

    Learn more →
    AMD
    41/100
    Narrow Moat
    70+ Wide · 40-69 Narrow · <40 None

    Narrow moat with reinvestment efficiency as the key competitive advantage. Improving roic consistency would strengthen the moat.

    Composite score measuring competitive advantage durability across four dimensions: returns above cost of capital, pricing power stability, revenue predictability, and capital efficiency. Based on 4 years of fundamental data.
    HCA
    95/100
    Wide Moat
    70+ Wide · 40-69 Narrow · <40 None

    Wide moat with strength across all dimensions. ROIC Consistency is the standout factor.

    Composite score measuring competitive advantage durability across four dimensions: returns above cost of capital, pricing power stability, revenue predictability, and capital efficiency. Based on 5 years of fundamental data.

    Forensic Accounting

    Learn more →
    AMD
    -2.84
    Unlikely Manipulator
    Above -1.78 = likely manipulator · -2.22 to -1.78 = grey zone

    M-Score Trend

    Beneish's 8-variable model estimates the probability of earnings manipulation. An M-Score above -1.78 signals elevated risk — companies in this range have historically been 3-5× more likely to be manipulating earnings. Scores between -2.22 and -1.78 fall in a grey zone warranting further investigation.
    HCA
    -2.78
    Unlikely Manipulator
    Above -1.78 = likely manipulator · -2.22 to -1.78 = grey zone

    M-Score Trend

    Beneish's 8-variable model estimates the probability of earnings manipulation. An M-Score above -1.78 signals elevated risk — companies in this range have historically been 3-5× more likely to be manipulating earnings. Scores between -2.22 and -1.78 fall in a grey zone warranting further investigation.

    Beneish's 8-variable model estimates the probability of earnings manipulation. An M-Score above -1.78 signals elevated risk — companies in this range have historically been 3-5× more likely to be manipulating earnings. Scores between -2.22 and -1.78 fall in a grey zone warranting further investigation.

    Ownership Breakdown

    Learn more →
    AMD
    Insiders 0.4%Institutions 72.2%Retail & Other 27.4%
    No. of Institutional Holders4,190
    High insider ownership aligns management incentives with shareholders — a key signal in Buffett-style analysis. Institutional concentration can indicate smart-money conviction but also crowding risk.
    HCA
    Insiders 16.2%Institutions 78.3%Retail & Other 5.5%
    No. of Institutional Holders1,952
    High insider ownership aligns management incentives with shareholders — a key signal in Buffett-style analysis. Institutional concentration can indicate smart-money conviction but also crowding risk.

    High insider ownership aligns management incentives with shareholders. Institutional concentration can indicate smart-money conviction but also crowding risk.

    Insider Buying Activity

    Learn more →
    AMD
    0
    Buys (3M)
    0
    Buys (12M)
    GUIDO PHILIP
    Officer
    $999,328
    @ $113.56 · 2025-05-20
    GUIDO PHILIP
    Officer
    $499,616
    @ $107.56 · 2025-02-07
    Open market purchases · includes direct & indirect ownership · excludes option exercises
    HCA
    0
    Buys (3M)
    0
    Buys (12M)
    No open market insider purchases found.
    Open market purchases · includes direct & indirect ownership · excludes option exercises

    Open market purchases · includes direct & indirect ownership · excludes option exercises.

    Insider Selling Activity

    Learn more →
    AMD
    8
    Sells (3M)
    31
    Sells (12M)
    Total value (12M): $308.72M
    SU LISA T
    Chief Executive Officer
    $57.59M
    @ $460.69 · 2026-06-10
    DENZEL NORA M
    Director
    $5.45M
    @ $522.00 · 2026-06-02
    NORROD FORREST EUGENE
    Officer
    $8.41M
    @ $431.40 · 2026-05-20
    SU LISA T
    Chief Executive Officer
    $55.69M
    @ $445.51 · 2026-05-13
    GRASBY PAUL DARREN
    Officer
    $10.83M
    @ $444.39 · 2026-05-08
    PAPERMASTER MARK D
    Chief Technology Officer
    $10.96M
    @ $350.00 · 2026-04-24
    PAPERMASTER MARK D
    Chief Technology Officer
    $8.99M
    @ $271.47 · 2026-04-16
    PAPERMASTER MARK D
    Chief Technology Officer
    $740,925
    @ $225.00 · 2026-04-06
    SU LISA T
    Chief Executive Officer
    $16.90M
    @ $198.77 · 2026-03-12
    GRASBY PAUL DARREN
    Officer
    $1.54M
    @ $204.87 · 2026-03-11
    PAPERMASTER MARK D
    Chief Technology Officer
    $606,800
    @ $200.00 · 2026-03-04
    HAHN AVA M
    General Counsel
    $56,814
    @ $198.65 · 2026-02-18
    HU JEAN X
    Chief Financial Officer
    $4.02M
    @ $201.62 · 2026-02-17
    SU LISA T
    Chief Executive Officer
    $26.79M
    @ $214.36 · 2026-02-11
    NORROD FORREST EUGENE
    Officer
    $4.22M
    @ $216.81 · 2026-02-11
    HAHN AVA M
    General Counsel
    $572,454
    @ $234.42 · 2026-01-16
    SU LISA T
    Chief Executive Officer
    $26.89M
    @ $215.14 · 2025-12-11
    GRASBY PAUL DARREN
    Officer
    $2.19M
    @ $218.77 · 2025-12-04
    HU JEAN X
    Chief Financial Officer
    $3.05M
    @ $209.96 · 2025-11-24
    NORROD FORREST EUGENE
    Officer
    $4.46M
    @ $229.37 · 2025-11-19
    PAPERMASTER MARK D
    Chief Technology Officer
    $4.11M
    @ $240.12 · 2025-11-14
    PAPERMASTER MARK D
    Chief Technology Officer
    $3.77M
    @ $224.28 · 2025-10-15
    HAHN AVA M
    General Counsel
    $648,197
    @ $226.01 · 2025-10-06
    NORROD FORREST EUGENE
    Officer
    $371,272
    @ $165.01 · 2025-09-24
    PAPERMASTER MARK D
    Chief Technology Officer
    $2.67M
    @ $159.20 · 2025-09-15
    NORROD FORREST EUGENE
    Officer
    $2.77M
    @ $160.93 · 2025-09-10
    HAHN AVA M
    General Counsel
    $22,608
    @ $158.10 · 2025-09-02
    SU LISA T
    Chief Executive Officer
    $36.89M
    @ $163.97 · 2025-08-21
    PAPERMASTER MARK D
    Chief Technology Officer
    $2.99M
    @ $178.11 · 2025-08-15
    GRASBY PAUL DARREN
    Officer
    $1.73M
    @ $173.21 · 2025-08-12
    PAPERMASTER MARK D
    Chief Technology Officer
    $2.79M
    @ $155.03 · 2025-07-15
    PAPERMASTER MARK D
    Chief Technology Officer
    $2.03M
    @ $116.00 · 2025-06-13
    PAPERMASTER MARK D
    Chief Technology Officer
    $2.04M
    @ $116.59 · 2025-05-15
    PAPERMASTER MARK D
    Chief Technology Officer
    $1.67M
    @ $95.47 · 2025-04-15
    PAPERMASTER MARK D
    Chief Technology Officer
    $1.75M
    @ $100.27 · 2025-03-14
    PAPERMASTER MARK D
    Chief Technology Officer
    $1.99M
    @ $113.57 · 2025-02-14
    SU LISA T
    Chief Executive Officer
    $10.91M
    @ $142.66 · 2024-12-04
    SU LISA T
    Chief Executive Officer
    $10.91M
    @ $142.66 · 2024-12-04
    SU LISA T
    Chief Executive Officer
    $11.51M
    @ $143.87 · 2024-11-06
    NORROD FORREST EUGENE
    Officer
    $5.74M
    @ $141.67 · 2024-11-05
    SU LISA T
    Chief Executive Officer
    $11.58M
    @ $144.72 · 2024-09-11
    SU LISA T
    Chief Executive Officer
    $12.60M
    @ $157.44 · 2024-08-20
    PAPERMASTER MARK D
    Chief Technology Officer
    $3.09M
    @ $184.50 · 2024-07-15
    Direct ownership only · excludes indirect, option exercises, planned (10b5-1) sales & derivatives
    HCA
    0
    Sells (3M)
    7
    Sells (12M)
    Total value (12M): $32.73M
    MCALEVEY MICHAEL R.
    Officer
    $903,537
    @ $533.37 · 2026-02-18
    WYATT CHRISTOPHER F
    Officer
    $2.02M
    @ $505.00 · 2026-02-11
    BERRES JENNIFER
    Officer
    $4.13M
    @ $514.58 · 2026-02-11
    HAZEN SAMUEL N
    Chief Executive Officer
    $21.48M
    @ $501.04 · 2026-02-03
    CUFFE MICHAEL S
    Officer
    $747,135
    @ $498.09 · 2026-02-03
    MCALEVEY MICHAEL R.
    Officer
    $1.84M
    @ $473.79 · 2025-11-05
    CUFFE MICHAEL S
    Officer
    $1.61M
    @ $418.84 · 2025-09-08
    FOSTER JON MARK
    Officer
    $5.80M
    @ $369.32 · 2025-05-13
    BERRES JENNIFER
    Officer
    $3.08M
    @ $322.59 · 2025-02-14
    BILLINGTON PHILLIP G
    Officer
    $1.36M
    @ $350.00 · 2024-11-14
    WHALEN KATHLEEN M
    Officer
    $527,677
    @ $357.99 · 2024-11-14
    AKDAMAR EROL R
    Officer
    $1.02M
    @ $353.00 · 2024-11-14
    CUFFE MICHAEL S
    Officer
    $3.22M
    @ $385.42 · 2024-09-12
    WHALEN KATHLEEN M
    Officer
    $1.76M
    @ $362.13 · 2024-07-31
    WYATT CHRISTOPHER F
    Officer
    $1.44M
    @ $360.20 · 2024-07-29
    REINER DEBORAH M
    Officer
    $1.19M
    @ $359.96 · 2024-07-29
    TORRES KATHRYN A
    Officer
    $659,328
    @ $355.05 · 2024-07-25
    Direct ownership only · excludes indirect, option exercises, planned (10b5-1) sales & derivatives

    Direct ownership only · excludes indirect, option exercises, planned (10b5-1) sales & derivatives.

    🎭 Mr. Market's Mood

    Learn more →
    AMD
    FearGreed
    😏Greed(61/100)

    "Market is optimistic — be cautious and ensure you have a margin of safety"

    Composite sentiment score based on 6 market signals. Inspired by Buffett's "Mr. Market" allegory — fear = potential opportunity, greed = potential risk. Must be used alongside fundamental analysis, not in isolation.
    HCA
    FearGreed
    😨Fear(39/100)

    "Market is pessimistic — investigate whether fears are temporary or structural"

    Composite sentiment score based on 6 market signals. Inspired by Buffett's "Mr. Market" allegory — fear = potential opportunity, greed = potential risk. Must be used alongside fundamental analysis, not in isolation.

    Composite sentiment score based on market signals. Inspired by Buffett’s "Mr. Market" allegory — fear = potential opportunity, greed = potential risk. Must be used alongside fundamental analysis, not in isolation.

    ⚖️ Buffett Signal

    Learn more →
    AMD
    Awaiting DCF Data

    The Buffett Signal cross-references market sentiment with DCF valuation. Configure the DCF Analysis above to generate a signal.

    DCF Margin of Safety: N/AMr. Market's Mood: Greed (61)
    HCA
    Awaiting DCF Data

    The Buffett Signal cross-references market sentiment with DCF valuation. Configure the DCF Analysis above to generate a signal.

    DCF Margin of Safety: N/AMr. Market's Mood: Fear (39)
    View AMD Full AnalysisView HCA Full Analysis

    Frequently Asked Questions: AMD vs HCA

    Is Advanced Micro Devices, Inc. or HCA Healthcare, Inc. more undervalued in 2026?

    Based on our discounted cash flow model, HCA trades at a 28.2% margin of safety (intrinsic value $523 vs. price $375), compared to AMD's -144.8% margin of safety (intrinsic $219 vs. $537).

    Which stock has a wider economic moat, Advanced Micro Devices, Inc. or HCA Healthcare, Inc.?

    HCA scores 95/100 (Wide moat), while AMD scores 41/100 (Narrow moat). The moat score measures competitive advantage durability across ROIC consistency, margin stability, revenue predictability, and reinvestment efficiency.

    Is HCA Healthcare, Inc. in financial distress?

    HCA's Altman Z-Score of 2.7 places it in the Grey zone, signaling elevated bankruptcy risk. AMD scores 16.0 (Safe zone). The Altman Z-Score is a five-factor model that predicts insolvency within two years; scores below 1.81 indicate significant distress.

    Which company has better free cash flow, Advanced Micro Devices, Inc. or HCA Healthcare, Inc.?

    HCA Healthcare, Inc. (HCA) generates a 9.2% free cash flow yield, compared to Advanced Micro Devices, Inc.'s 0.8%. A higher FCF yield means the business converts more of its market value into cash that can be returned to shareholders or reinvested.

    Which stock has higher return on invested capital, Advanced Micro Devices, Inc. or HCA Healthcare, Inc.?

    HCA earns 18.1% ROIC versus AMD's 6.2%. A higher ROIC means the company generates more profit per dollar of capital employed, a hallmark of durable competitive advantage in Buffett-style analysis.